Former FDA regulatory section chief joins RegenMed Development Organization


The growing regenerative medicine hub in the Innovation Quarter added a key new player on Friday.

The RegenMed Development Organization (ReMDO) and its collaborative research partner, the Wake Forest Institute for Regenerative Medicine (WFIRM), announced that Steven R. Bauer, a former FDA official with 31 years of regulatory experience, clinical trials oversight and research experience in cell-based biological therapies, is joining the Regenerative Medicine Hub endeavor.

Bauer's title was not…

Previous Maryland biotech subsidiary gets $50M in funding to further cell therapy manufacturing
Next Atrium Health, Advocate Aurora complete deal to become fifth-largest U.S. health system